Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Synthesis, In Silico Study, and Anti-Cancer Activity of Thiosemicarbazone Derivatives

BZ. Sibuh, PK. Gupta, P. Taneja, S. Khanna, P. Sarkar, S. Pachisia, AA. Khan, NK. Jha, K. Dua, SK. Singh, S. Pandey, P. Slama, KK. Kesari, S. Roychoudhury

. 2021 ; 9 (10) : . [pub] 20211001

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001637

Thiosemicarbazones are known for their biological and pharmacological activities. In this study, we have synthesized and characterized 3-Methoxybenzaldehyde thiosemicarbazone (3-MBTSc) and 4-Nitrobenzaldehyde thiosemicarbazone (4-NBTSc) using IR, 1HNMR and 13C NMR. The compound's in vitro anticancer activities against different cell lines were evaluated. Molecular docking, Insilco ADMET, and drug-likeness prediction were also done. The test compounds showed a comparative IC50 and growth inhibition with the standard drug Doxorubicin. The IC50 ranges from 2.82 μg/mL to 14.25 μg/mL in 3-MBTSc and 2.80 μg/mL to 7.59 μg/mL in 4-NBTSc treated cells. The MTT assay result revealed, 3-MBTSc inhibits 50.42 and 50.31 percent of cell growth in B16-F0 and EAC cell lines, respectively. The gene expression showed that tumor suppressor genes such as PTEN and BRCA1 are significantly upregulated in 7.42 and 5.33 folds, and oncogenes, PKC, and RAS are downregulated -7.96 and -7.64 folds, respectively in treated cells. The molecular docking performed on the four targeted proteins (PARP, VEGFR-1, TGF-β1, and BRAFV600E) indicated that both 4-NBTSc and 3-MBTSc potentially bind to TGF-β1 with the best binding energy of -42.34 Kcal/mol and -32.13 Kcal/mol, respectively. In addition, the test compound possesses desirable ADMET and drug-likeness properties. Overall, both 3-MBTSc and 4-NBTSc have the potential to be multitargeting drug candidates for further study. Moreover, 3-MBTSc showed better activity than 4-NBTSc.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001637
003      
CZ-PrNML
005      
20250819152615.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines9101375 $2 doi
035    __
$a (PubMed)34680491
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sibuh, Belay Zeleke $u Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Knowledge Park III, Greater Noida 201310, Uttar Pradesh, India
245    10
$a Synthesis, In Silico Study, and Anti-Cancer Activity of Thiosemicarbazone Derivatives / $c BZ. Sibuh, PK. Gupta, P. Taneja, S. Khanna, P. Sarkar, S. Pachisia, AA. Khan, NK. Jha, K. Dua, SK. Singh, S. Pandey, P. Slama, KK. Kesari, S. Roychoudhury
520    9_
$a Thiosemicarbazones are known for their biological and pharmacological activities. In this study, we have synthesized and characterized 3-Methoxybenzaldehyde thiosemicarbazone (3-MBTSc) and 4-Nitrobenzaldehyde thiosemicarbazone (4-NBTSc) using IR, 1HNMR and 13C NMR. The compound's in vitro anticancer activities against different cell lines were evaluated. Molecular docking, Insilco ADMET, and drug-likeness prediction were also done. The test compounds showed a comparative IC50 and growth inhibition with the standard drug Doxorubicin. The IC50 ranges from 2.82 μg/mL to 14.25 μg/mL in 3-MBTSc and 2.80 μg/mL to 7.59 μg/mL in 4-NBTSc treated cells. The MTT assay result revealed, 3-MBTSc inhibits 50.42 and 50.31 percent of cell growth in B16-F0 and EAC cell lines, respectively. The gene expression showed that tumor suppressor genes such as PTEN and BRCA1 are significantly upregulated in 7.42 and 5.33 folds, and oncogenes, PKC, and RAS are downregulated -7.96 and -7.64 folds, respectively in treated cells. The molecular docking performed on the four targeted proteins (PARP, VEGFR-1, TGF-β1, and BRAFV600E) indicated that both 4-NBTSc and 3-MBTSc potentially bind to TGF-β1 with the best binding energy of -42.34 Kcal/mol and -32.13 Kcal/mol, respectively. In addition, the test compound possesses desirable ADMET and drug-likeness properties. Overall, both 3-MBTSc and 4-NBTSc have the potential to be multitargeting drug candidates for further study. Moreover, 3-MBTSc showed better activity than 4-NBTSc.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gupta, Piyush Kumar $u Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Greater Noida 201310, Uttar Pradesh, India
700    1_
$a Taneja, Pankaj $u Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Knowledge Park III, Greater Noida 201310, Uttar Pradesh, India
700    1_
$a Khanna, Sonia $u Department of Chemistry and Biochemistry, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Greater Noida 201310, Uttar Pradesh, India
700    1_
$a Sarkar, Paratpar $u Department of Chemistry and Biochemistry, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Greater Noida 201310, Uttar Pradesh, India
700    1_
$a Pachisia, Sanya $u Department of Chemistry, University of Delhi, New Delhi 110007, Delhi, India
700    1_
$a Khan, Abrar Ali $u Department of Biotechnology, Indian Institute of Technology, Chennai 600036, Tamilnadu, India
700    1_
$a Jha, Niraj Kumar $u Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Knowledge Park III, Greater Noida 201310, Uttar Pradesh, India
700    1_
$a Dua, Kamal $u Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia
700    1_
$a Singh, Sachin Kumar $u School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144001, Punjab, India
700    1_
$a Pandey, Sadanand $u Department of Chemistry, College of Natural Science, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Gyeongbuk, Korea
700    1_
$a Slama, Petr $u Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, 61300 Brno, Czech Republic
700    1_
$a Kesari, Kavindra Kumar $u Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, 00076 Espoo, Finland
700    1_
$a Roychoudhury, Shubhadeep $u Department of Life Science and Bioinformatics, Assam University, Silchar 788011, Assam, India $7 xx0334841
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 9, č. 10 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34680491 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20250819152557 $b ABA008
999    __
$a ind $b bmc $g 1745551 $s 1152784
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 9 $c 10 $e 20211001 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace